Meddo has announced its acquisition of Doxper in a cash and stock deal. With this acquisition, Meddo is cementing its place as one of the largest health-tech players in the country in the outpatient care space with more than 1.5 crore digitised prescriptions and over 1 crore patients, further adding another 3-4 Lakh patients every month to their base. Doxper is a leader in the prescription digitisation space, with a strong client base of 4000+ doctors

Saurabh Kochhar, Founder, and CEO, Meddo said, “This acquisition is just the leap needed in this very direction. Enabling Meddo’s one-stop care for millions of patients across the Doxper network, in addition to their prescription technology, creates the right ecosystem to fundamentally transform outpatient care, which has been our goal from the get-go.”

Shailesh Prithani, Co-Founder & CEO, Doxper said, “We truly believe in Meddo’s omni-channel fulfilment led approach and are excited to join this transformative journey. We are confident that our integration will enhance and improve clinical outcomes for clinicians and patients.”

With Doxper in its fold, Meddo plans to scale up its branded full suite clinics to 1000 plus within the next 12-15 months across the 10 top-tier markets within the country. In the last few months, the venture launched relevant solutions like L1 COVID centres, teleconsultation services, diagnostic solutions and an extremely useful and cost-effective healthcare membership called MeddoSure.